Rheumnow
ACR2021 - Day5a
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:28:44
- Mas informaciones
Informações:
Sinopsis
Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim Potpourri of Biosimilar Trials: Dr. Jonathan Kay Closing a Chapter: Interview with the 84th ACR President 2020-2021, Kathryn Dao
